<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Pan Y</submitter><funding>Veterans Administration</funding><funding>NIDDK NIH HHS</funding><funding>NIH-NIDDK</funding><funding>National Natural Science Foundation of China</funding><funding>NIDDK</funding><pagination>e152391</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9057601</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>132(9)</volume><pubmed_abstract>Obesity-associated complications are causing increasing morbidity and mortality worldwide. Expansion of adipose tissue in obesity leads to a state of low-grade chronic inflammation and dysregulated metabolism, resulting in insulin resistance and metabolic syndrome. Adipose tissue macrophages (ATMs) accumulate in obesity and are a source of proinflammatory cytokines that further aggravate adipocyte dysfunction. Macrophages are rich sources of cyclooxygenase (COX), the rate limiting enzyme for prostaglandin E2 (PGE2) production. When mice were fed a high-fat diet (HFD), ATMs increased expression of COX-2. Selective myeloid cell COX-2 deletion resulted in increased monocyte recruitment and proliferation of ATMs, leading to increased proinflammatory ATMs with decreased phagocytic ability. Ther</pubmed_abstract><journal>The Journal of clinical investigation</journal><pubmed_title>Cyclooxygenase-2 in adipose tissue macrophages limits adipose tissue dysfunction in obese mice.</pubmed_title><pmcid>PMC9057601</pmcid><funding_grant_id>00507969</funding_grant_id><funding_grant_id>81870490</funding_grant_id><funding_grant_id>R01 DK054902</funding_grant_id><funding_grant_id>U24 DK059637</funding_grant_id><funding_grant_id>DK51265</funding_grant_id><funding_grant_id>DK059637</funding_grant_id><funding_grant_id>DK62794</funding_grant_id><funding_grant_id>DK054902</funding_grant_id><funding_grant_id>DK95785</funding_grant_id><pubmed_authors>Pan Y</pubmed_authors><pubmed_authors>Fan X</pubmed_authors><pubmed_authors>Niu A</pubmed_authors><pubmed_authors>Wasserman DH</pubmed_authors><pubmed_authors>Jiang M</pubmed_authors><pubmed_authors>Arroyo JP</pubmed_authors><pubmed_authors>Terker AS</pubmed_authors><pubmed_authors>Tang J</pubmed_authors><pubmed_authors>Harris RC</pubmed_authors><pubmed_authors>Zhang MZ</pubmed_authors><pubmed_authors>Wang S</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Cao S</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cyclooxygenase-2 in adipose tissue macrophages limits adipose tissue dysfunction in obese mice.</name><description>Obesity-associated complications are causing increasing morbidity and mortality worldwide. Expansion of adipose tissue in obesity leads to a state of low-grade chronic inflammation and dysregulated metabolism, resulting in insulin resistance and metabolic syndrome. Adipose tissue macrophages (ATMs) accumulate in obesity and are a source of proinflammatory cytokines that further aggravate adipocyte dysfunction. Macrophages are rich sources of cyclooxygenase (COX), the rate limiting enzyme for prostaglandin E2 (PGE2) production. When mice were fed a high-fat diet (HFD), ATMs increased expression of COX-2. Selective myeloid cell COX-2 deletion resulted in increased monocyte recruitment and proliferation of ATMs, leading to increased proinflammatory ATMs with decreased phagocytic ability. Ther</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 May</publication><modification>2025-04-04T14:49:26.425Z</modification><creation>2025-04-04T14:49:26.425Z</creation></dates><accession>S-EPMC9057601</accession><cross_references><pubmed>35499079</pubmed><doi>10.1172/JCI152391</doi></cross_references></HashMap>